Board of Directors
Peter Lawrence (Chairman)
(Date of Appointment 30 November 1999; became Chairman 14 December 2009)
(age 61) is chairman of ECO Animal Health Group plc, which is traded on AIM. Peter set up this company in 1972, which has experienced considerable growth and made several acquisitions and disposals since then. As a director of Higher Nature Limited and Kiotech International plc, both VCT backed companies, he has an in-depth understanding of the typical operational and strategic issues facing the type of investees within the portfolio of Baronsmead VCT. In 2003 he became ‘entrepreneur of the year' selected from over 700 AIM companies. He is also a director of Noble AIM VCT plc.
Andrew Crossley
(Date of Appointment 19 March 1999)
(age 46) has extensive experience of portfolio management and the valuation of smaller quoted companies, which is particularly relevant for the valuation of unquoted and AIM investees within Baronsmead VCT. Andy has managed the smaller company investment trust, INVESCO English and International Investment Trust plc at INVESCO Perpetual since 1991 and more recently manages INVESCO Perpetual AIM VCT plc and he also sits on the AIM Advisory Committee.
Godfrey Jillings
(Date of Appointment 27 July 1995)
(age 69) is non-executive chairman of Spring Studios. He held a range of senior executive appointments at NatWest including responsibility for their retail stockbroking, unit trust and PEP operations. He was chief executive officer of FIMBRA, the regulatory body for IFAs and a deputy chief executive officer of its successor PIA (1990-1994). He was chairman of Ma Potter's until a successful trade sale and deputy chairman of DBS plc (1996-2002), the leading IFA network prior to its take-over. He was deputy chairman of Gladedale Holdings Limited until its sale earlier this year. He is also a director of Baronsmead VCT 2.
Valerie Marshall
(Date of appointment 12 November 2009)
(age 64) has wide experience of private equity at 3i and the Scottish Development Agency prior to specialising in corporate finance. She is CEO of Stratagem Corporate Finance and Strategy Limited, Chair of University of Kent, a non executive director of Nano Bio Design Limited, Fusion Lifestyle Limited and Marshall Capital Limited. She was formerly Corporate Finance Director at Greig Middleton & Co Ltd.


